<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="https://www.accessdata.fda.gov/spl/stylesheet/spl.xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 https://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="1fddaa59-14d4-4339-8e9c-1c479499a4b7"/>
   <code code="34391-3" displayName="HUMAN PRESCRIPTION DRUG LABEL" codeSystem="2.16.840.1.113883.6.1"/>
   <title>Diphenhydramine Hydrochloride Injection,
        USP<br/>Rx only</title>
   <effectiveTime value="20250403"/>
   <setId root="829bbcbf-fb27-4484-aff6-a7e7467670af"/>
   <versionNumber value="3"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="946499746" root="1.3.6.1.4.1.519.1"/>
            <name>Hikma Pharmaceuticals USA Inc.</name>
            <assignedEntity>
               <assignedOrganization>
                  <id extension="001230762" root="1.3.6.1.4.1.519.1"/>
                  <name>Hikma Pharmaceuticals USA Inc.</name>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="946499746" root="1.3.6.1.4.1.519.1"/>
                        <name>Hikma Pharmaceuticals USA Inc.</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C25391" displayName="analysis" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0641-6282" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C84732" displayName="label" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0641-6282" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C43360" displayName="manufacture" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <product>
                              <manufacturedProduct classCode="MANU">
                                 <manufacturedMaterialKind>
                                    <code code="0641-6282" codeSystem="2.16.840.1.113883.6.69"/>
                                 </manufacturedMaterialKind>
                              </manufacturedProduct>
                           </product>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="7953eb36-2f7f-456c-8f7b-0c4eb5d7958f"/>
               <code code="48780-1" displayName="SPL listing data elements section" codeSystem="2.16.840.1.113883.6.1"/>
               <effectiveTime value="20250403"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code code="0641-6282" codeSystem="2.16.840.1.113883.6.69"/>
                        <name>Diphenhydramine hydrochloride</name>
                        <formCode code="C42946" displayName="INJECTION" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>diphenhydramine hydrochloride</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator unit="mg" value="50"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="TC2D6JAD40" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>DIPHENHYDRAMINE HYDROCHLORIDE</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="8GTS82S83M" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>DIPHENHYDRAMINE</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <quantity>
                              <numerator unit="ug" value="100"/>
                              <denominator unit="mL" value="1"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="PH41D05744" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>BENZETHONIUM CHLORIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>WATER</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="55X04QC32I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>SODIUM HYDROXIDE</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="QTT17582CB" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>HYDROCHLORIC ACID</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator unit="mL" value="1"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code code="0641-6282-01" codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43226" displayName="VIAL" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                              <asContent>
                                 <quantity>
                                    <numerator unit="1" value="25"/>
                                    <denominator value="1"/>
                                 </quantity>
                                 <containerPackagedProduct>
                                    <code code="0641-6282-25" codeSystem="2.16.840.1.113883.6.69"/>
                                    <formCode code="C43233" displayName="PACKAGE" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                 </containerPackagedProduct>
                                 <subjectOf>
                                    <marketingAct>
                                       <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                                       <statusCode code="active"/>
                                       <effectiveTime>
                                          <low value="19721127"/>
                                       </effectiveTime>
                                    </marketingAct>
                                 </subjectOf>
                              </asContent>
                           </containerPackagedProduct>
                           <subjectOf>
                              <characteristic>
                                 <code code="SPLCMBPRDTP" codeSystem="2.16.840.1.113883.1.11.19255"/>
                                 <value code="C112160" displayName="Type 0: Not a Combination Product" codeSystem="2.16.840.1.113883.3.26.1.1" xsi:type="CV"/>
                              </characteristic>
                           </subjectOf>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="ANDA080817" root="2.16.840.1.113883.3.150"/>
                           <code code="C73584" displayName="ANDA" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19721127"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C28161" displayName="INTRAMUSCULAR" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                        </substanceAdministration>
                     </consumedIn>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38276" displayName="INTRAVENOUS" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="LINK_d55e93dd-1d26-4fef-af73-cd47bfbcf0ca">
               <id root="0ee1d19e-ac65-43b0-a8a1-e47e4b1ee40a"/>
               <code code="34089-3" codeSystem="2.16.840.1.113883.6.1" displayName="DESCRIPTION SECTION"/>
               <title>DESCRIPTION</title>
               <text>
                  <paragraph>Diphenhydramine Hydrochloride Injection is a sterile, nonpyrogenic solution for intravenous or deep intramuscular use as an antihistaminic agent. Each mL contains diphenhydramine hydrochloride 50 mg and benzethonium chloride 100 mcg in Water for Injection. pH 4.0-6.5; sodium hydroxide and/or hydrochloric acid added, if needed, for pH adjustment.</paragraph>
                  <paragraph>The chemical name of diphenhydramine hydrochloride is 2-(Diphenylmethoxy)-N,N-dimethylethylamine hydrochloride. The structural formula is as follows:</paragraph>
                  <renderMultiMedia referencedObject="MM1"/>
                  <paragraph>C<sub>17</sub>H<sub>21</sub>NO • HCl MW 291.82</paragraph>
                  <paragraph>Diphenhydramine hydrochloride occurs as a white crystalline powder and is freely soluble in water and alcohol.</paragraph>
               </text>
               <effectiveTime value="20250403"/>
               <component>
                  <observationMedia ID="MM1">
                     <text>structure</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="diphenhydramine-novaplus-1.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_fe3f31bc-4ff7-402b-9fc9-d8437694cde9">
               <id root="7b0fab6d-5c7b-4052-83d9-2aa05c630fe7"/>
               <code code="34090-1" codeSystem="2.16.840.1.113883.6.1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>CLINICAL PHARMACOLOGY</title>
               <text>
                  <paragraph>Diphenhydramine hydrochloride is an antihistamine with anticholinergic (drying) and sedative side effects. Antihistamines appear to compete with histamine for cell receptor sites on effector cells.</paragraph>
                  <paragraph>Diphenhydramine hydrochloride in the injectable form has a rapid onset of action. Diphenhydramine is widely distributed throughout the body, including the CNS. A portion of the drug is excreted unchanged in the urine, while the rest is metabolized via the liver. Detailed information on the pharmacokinetics of Diphenhydramine Hydrochloride Injection is not available.</paragraph>
               </text>
               <effectiveTime value="20250403"/>
            </section>
         </component>
         <component>
            <section ID="LINK_f717cef2-b46d-4847-a2c7-6a19dc5eaff8">
               <id root="5d9e10c8-4ba7-4fcd-a6b5-41b43c12ee05"/>
               <code code="34067-9" codeSystem="2.16.840.1.113883.6.1" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>INDICATIONS AND USAGE</title>
               <text>
                  <paragraph>Diphenhydramine
                            Hydrochloride Injection is effective in adults and pediatric patients,
                            other than premature infants and neonates, for the following conditions
                            when the oral form is impractical:</paragraph>
               </text>
               <effectiveTime value="20250403"/>
               <component>
                  <section ID="LINK_489ab254-e43f-4171-8d3e-b482ea3c542d">
                     <id root="ecf09f2f-1b49-4c5b-9716-cc3a085390ff"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Antihistaminic</title>
                     <text>
                        <paragraph>For amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_6d0988f9-517f-47f8-96d7-22384ff91feb">
                     <id root="077d95a8-9020-424e-8de6-11bf7b354234"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Motion Sickness</title>
                     <text>
                        <paragraph>For active
                                    treatment of motion sickness.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_a0a9b8a5-8d5d-4b79-b6ce-121d8753ebf5">
                     <id root="8a2bf219-af4a-4318-b816-975115f046b1"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Antiparkinsonism</title>
                     <text>
                        <paragraph>For use in
                                    parkinsonism, when oral therapy is impossible or
                                    contraindicated, as follows: parkinsonism in the elderly who are
                                    unable to tolerate more potent agents, mild cases of
                                    parkinsonism in other age groups and in other cases of
                                    parkinsonism in combination with centrally acting
                                    anticholinergic agents.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_e05cfe8e-10ac-4da5-b009-bcbdef0dede5">
               <id root="7bc636ce-64b5-493b-9388-30718957781a"/>
               <code code="34070-3" codeSystem="2.16.840.1.113883.6.1" displayName="CONTRAINDICATIONS SECTION"/>
               <title>CONTRAINDICATIONS</title>
               <text/>
               <effectiveTime value="20250403"/>
               <component>
                  <section ID="LINK_7f571f45-78e1-4f1f-ab29-5cba798831ef">
                     <id root="d3893b0d-8487-4d90-8963-f4922fa0c639"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Use in Neonates or       Premature Infants</title>
                     <text>
                        <paragraph>This drug
                                    should <content styleCode="italics">
                              <content styleCode="underline">not</content>
                           </content> be
                                    used in neonates or premature infants.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_63642ecb-babe-40e9-98df-6eb3ff32baa2">
                     <id root="9ab2ff23-7764-4430-9ab1-b41e55faab31"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Use in Nursing
                                Mothers</title>
                     <text>
                        <paragraph>Because of
                                    the higher risk of antihistamines for infants generally, and for
                                    neonates and prematures in particular, antihistamine therapy is
                                    contraindicated in nursing mothers.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_f6f68994-736c-4f9b-a45c-f69a437272f6">
                     <id root="41639b16-bb62-4e43-b118-f7e7ffe44ed2"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Use as a Local
                                Anesthetic</title>
                     <text>
                        <paragraph>Because of
                                    the risk of local necrosis, this drug should not be used as a
                                    local anesthetic.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_25789181-85ba-4fa4-8719-89d76bc70481">
                     <id root="512e5d10-5a33-4955-b654-0f9a0a196c6c"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Antihistamines are
                                also Contraindicated in the Following Conditions</title>
                     <text>
                        <paragraph>Hypersensitivity to diphenhydramine hydrochloride and other
                                    antihistamines of similar chemical structure.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_f5835d68-e1e2-4b66-be15-00961249eb54">
               <id root="4fa02979-4bf2-448b-94d9-6e3b0dab02ac"/>
               <code code="34071-1" codeSystem="2.16.840.1.113883.6.1" displayName="WARNINGS SECTION"/>
               <title>WARNINGS</title>
               <text>
                  <paragraph>Antihistamines
                            should be used with considerable caution in patients with narrow-angle
                            glaucoma, stenosing peptic ulcer, pyloroduodenal obstruction,
                            symptomatic prostatic hypertrophy or bladder-neck obstruction.</paragraph>
                  <paragraph>Local necrosis has
                            been associated with the use of subcutaneous or intradermal use of
                            intravenous diphenhydramine.</paragraph>
               </text>
               <effectiveTime value="20250403"/>
               <component>
                  <section ID="LINK_e0accdcb-1fc2-4a2a-b032-1cfd3420679e">
                     <id root="d0b593dd-9ac6-44ae-b093-e22d7c9ef982"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Use in Pediatric
                                Patients</title>
                     <text>
                        <paragraph>In
                                    pediatric patients, especially, antihistamines in <content styleCode="italics">overdosage</content> may cause
                                    hallucinations, convulsions or death.</paragraph>
                        <paragraph>As in
                                    adults, antihistamines may diminish mental alertness in
                                    pediatric patients. In the young pediatric patient,
                                    particularly, they may produce excitation.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_35a1d542-5fd8-479d-9ddf-e2ecf7d532b7">
                     <id root="a4e51ec8-70d9-4fec-9bdc-a3511a1e73cb"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Use in the Elderly
                                (approximately 60 years or older)</title>
                     <text>
                        <paragraph>Antihistamines are more likely to cause dizziness, sedation and
                                    hypotension in elderly patients.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_e280a157-d4fe-4ff3-9e67-a74f88c5bdd1">
               <id root="fd2a2ae4-05e7-4c07-ad67-a37c92a4214e"/>
               <code code="34072-9" codeSystem="2.16.840.1.113883.6.1" displayName="GENERAL PRECAUTIONS SECTION"/>
               <title>PRECAUTIONS</title>
               <text/>
               <effectiveTime value="20250403"/>
               <component>
                  <section ID="LINK_9f62c501-cd94-4e45-a549-51efc4d7259f">
                     <id root="53ec9172-5405-40f0-a838-14bea161f4c0"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>General</title>
                     <text>
                        <paragraph>Diphenhydramine hydrochloride has an atropine-like action and,
                                    therefore, should be used with caution in patients with a
                                    history of bronchial asthma, increased intraocular pressure,
                                    hyperthyroidism, cardiovascular disease or hypertension. Use
                                    with caution in patients with lower respiratory disease,
                                    including asthma.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_f06576c3-b5bd-4f6f-a133-333ec53cbeb2">
                     <id root="0cacce2b-5251-47d8-8c0d-9f2bc52fac58"/>
                     <code code="34076-0" codeSystem="2.16.840.1.113883.6.1" displayName="INFORMATION FOR PATIENTS SECTION"/>
                     <title>Information for
                                Patients</title>
                     <text>
                        <paragraph>Patients
                                    taking diphenhydramine hydrochloride should be advised that this
                                    drug may cause drowsiness and has an additive effect with
                                    alcohol.</paragraph>
                        <paragraph>Patients
                                    should be warned about engaging in activities requiring mental
                                    alertness, such as driving a car or operating appliances,
                                    machinery, etc.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_936d5eae-d962-4e83-8c2e-838fa07b7857">
                     <id root="96059f01-a249-4069-9856-b15bcd1696fb"/>
                     <code code="34073-7" codeSystem="2.16.840.1.113883.6.1" displayName="DRUG INTERACTIONS SECTION"/>
                     <title>Drug Interactions</title>
                     <text>
                        <paragraph>Diphenhydramine hydrochloride has additive effects with alcohol
                                    and other CNS depressants (hypnotics, sedatives, tranquilizers,
                                    etc.)</paragraph>
                        <paragraph>MAO
                                    inhibitors prolong and intensify the anticholinergic (drying)
                                    effects of antihistamines.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_19beac30-fb7a-4af4-a59b-25b6f3de1758">
                     <id root="9aa3208d-1a02-496a-be01-196c0fa94fc3"/>
                     <code code="34083-6" codeSystem="2.16.840.1.113883.6.1" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title>Carcinogenesis,
                                Mutagenesis, Impairment of Fertility</title>
                     <text>
                        <paragraph>Long-term
                                    studies in animals to determine mutagenic and carcinogenic
                                    potential have not been performed.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_a846e134-a2a7-4182-bd4d-58972387ce1b">
                     <id root="8a25e2bf-b4e8-4533-8f88-fec305ff3f3f"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Pregnancy</title>
                     <text/>
                     <effectiveTime value="20250403"/>
                     <component>
                        <section ID="LINK_0fbc3add-a8e3-4d51-8f44-aa761258710d">
                           <id root="f5be6605-21c1-47b5-a482-c48ca273f26c"/>
                           <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                           <title>Teratogenic
                                        Effects—Pregnancy Category B</title>
                           <text>
                              <paragraph>Reproduction studies have been performed in rats and
                                            rabbits at doses up to 5 times the human dose and have
                                            revealed no evidence of impaired fertility or harm to
                                            the fetus due to diphenhydramine hydrochloride. There
                                            are, however, no adequate and well-controlled studies in
                                            pregnant women. Because animal reproduction studies are
                                            not always predictive of human response, this drug
                                            should be used during pregnancy only if clearly
                                        needed.</paragraph>
                           </text>
                           <effectiveTime value="20250403"/>
                        </section>
                     </component>
                  </section>
               </component>
               <component>
                  <section ID="LINK_aca4b4b3-6b20-4a0c-8d51-b0447cf35455">
                     <id root="a980e4dc-553c-4aaf-9a21-4bee1c6c9631"/>
                     <code code="34081-0" codeSystem="2.16.840.1.113883.6.1" displayName="PEDIATRIC USE SECTION"/>
                     <title>Pediatric Use</title>
                     <text>
                        <paragraph>Diphenhydramine should not be used in neonates and premature infants (see <content styleCode="bold">
                              <linkHtml href="#LINK_e05cfe8e-10ac-4da5-b009-bcbdef0dede5">CONTRAINDICATIONS</linkHtml>
                           </content>).</paragraph>
                        <paragraph>Diphenhydramine may diminish mental alertness, or in the young pediatric patient, cause excitation. Overdosage may cause hallucinations, convulsions or death (see <content styleCode="bold">
                              <linkHtml href="#LINK_f5835d68-e1e2-4b66-be15-00961249eb54">WARNINGS</linkHtml>
                           </content> and <content styleCode="bold">
                              <linkHtml href="#LINK_34992d98-574d-4e38-af2f-420c1d63f147">OVERDOSAGE</linkHtml>
                           </content>).</paragraph>
                        <paragraph>See also <content styleCode="bold">
                              <linkHtml href="#LINK_674f09a3-f703-4c35-9a13-2a4147e554be">DOSAGE AND ADMINISTRATION</linkHtml>
                           </content> section.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_51a5b33c-9f24-46b9-a16c-b8fd9b97b3e1">
               <id root="cfc2109c-6c73-428a-97b9-8d40b45869d5"/>
               <code code="34084-4" codeSystem="2.16.840.1.113883.6.1" displayName="ADVERSE REACTIONS SECTION"/>
               <title>ADVERSE REACTIONS</title>
               <text>
                  <paragraph>The most frequent
                            adverse reactions are italicized.</paragraph>
               </text>
               <effectiveTime value="20250403"/>
               <component>
                  <section ID="LINK_8bfb7099-3c85-4b5f-bf44-bf6475dc2a22">
                     <id root="53df9429-2b5d-49a2-bb17-35b36d497517"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>General</title>
                     <text>
                        <paragraph>Urticaria;
                                    drug rash; anaphylactic shock; photosensitivity; excessive
                                    perspiration; chills; dryness of mouth, nose and
                                throat.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_caaa965a-b7e0-4b74-aeca-c150c17633ec">
                     <id root="f964283b-cbac-4323-9067-eea342df70e3"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Cardiovascular
                                System</title>
                     <text>
                        <paragraph>Hypotension, headache, palpitations, tachycardia,
                                    extrasystoles.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_c55cbccb-67c6-4b37-92a9-da681dfd2c01">
                     <id root="7456ea2c-54fc-42b0-9446-134a4bf5cde1"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Hematologic System</title>
                     <text>
                        <paragraph>Hemolytic
                                    anemia, thrombocytopenia, agranulocytosis.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_025df4c4-bb68-45c9-bf8d-cc83cf6be1d7">
                     <id root="095263df-5c81-4019-8ff7-a9d6c45f50ad"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Nervous System</title>
                     <text>
                        <paragraph>
                           <content styleCode="italics">Sedation</content>, <content styleCode="italics">sleepiness</content>, <content styleCode="italics">dizziness</content>, <content styleCode="italics">disturbed coordination</content>,
                                    fatigue, confusion, restlessness, excitation, nervousness,
                                    tremor, irritability, insomnia, euphoria, paresthesia, blurred
                                    vision, diplopia, vertigo, tinnitus, acute labyrinthitis,
                                    neuritis, convulsions.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_f420263a-d88e-4d1f-9dff-f73fec196698">
                     <id root="a603957f-2e66-49a0-af4f-911068e7491b"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Gastrointestinal
                                System</title>
                     <text>
                        <paragraph>
                           <content styleCode="italics">Epigastric distress</content>, anorexia,
                                    nausea, vomiting, diarrhea, constipation.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_d5e8b64b-a8ac-491d-9ef1-2e9fdbf9ac34">
                     <id root="f5eff6ce-43f4-4a57-9634-30f8e484d81a"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Genitourinary
                                System</title>
                     <text>
                        <paragraph>Urinary
                                    frequency, difficult urination, urinary retention, early
                                menses.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_588590bd-0d01-4d9e-a31a-7a57e4696318">
                     <id root="bedd17f7-7ee2-49e2-8d9f-8cd660d93914"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Respiratory System</title>
                     <text>
                        <paragraph>
                           <content styleCode="italics">Thickening of bronchial
                                    secretions</content>, tightness of chest and wheezing, nasal
                                    stuffiness.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_34992d98-574d-4e38-af2f-420c1d63f147">
               <id root="8540e45d-fd0f-4cbf-9cde-84824da9b8fc"/>
               <code code="34088-5" codeSystem="2.16.840.1.113883.6.1" displayName="OVERDOSAGE SECTION"/>
               <title>OVERDOSAGE</title>
               <text>
                  <paragraph>Antihistamine
                            overdosage reactions may vary from central nervous system depression to
                            stimulation. Stimulation is particularly likely in pediatric patients.
                            Atropine-like signs and symptoms, dry mouth; fixed, dilated pupils;
                            flushing, and gastrointestinal symptoms may also occur.</paragraph>
                  <paragraph>
                     <content styleCode="italics">Stimulants</content> should <content styleCode="bold">not</content> be used.</paragraph>
                  <paragraph>Vasopressors may be
                            used to treat hypotension.</paragraph>
               </text>
               <effectiveTime value="20250403"/>
            </section>
         </component>
         <component>
            <section ID="LINK_674f09a3-f703-4c35-9a13-2a4147e554be">
               <id root="705c788c-2bf5-4666-9b4d-047a98a6f7dd"/>
               <code code="34068-7" codeSystem="2.16.840.1.113883.6.1" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>DOSAGE AND ADMINISTRATION</title>
               <text>
                  <paragraph>THIS PRODUCT IS FOR
                            INTRAVENOUS OR INTRAMUSCULAR ADMINISTRATION ONLY.</paragraph>
                  <paragraph>Diphenhydramine
                            Hydrochloride Injection is indicated when the oral form is impractical.</paragraph>
                  <paragraph>DOSAGE SHOULD BE
                            INDIVIDUALIZED ACCORDING TO THE NEEDS AND THE RESPONSE OF THE
                        PATIENT.</paragraph>
               </text>
               <effectiveTime value="20250403"/>
               <component>
                  <section ID="LINK_98b6fa28-469a-4d23-9c7a-2ef0edaf850a">
                     <id root="c8d6f1b9-26cf-4b54-a3f0-8a784242df57"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Pediatric Patients,
                                Other Than Premature Infants and Neonates</title>
                     <text>
                        <paragraph>5 mg/kg/24
                                    hours or 150 mg/m<sup>2</sup>/24 hours. Maximum daily dosage is
                                    300 mg. Divide into four doses, administered intravenously at a
                                    rate generally not exceeding 25 mg/min, or deep
                                intramuscularly.</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
               <component>
                  <section ID="LINK_2685cef1-a1d0-4dd7-81cf-c08b7e845af8">
                     <id root="f809b068-fa42-447b-aced-0f86d74b821a"/>
                     <code code="42229-5" codeSystem="2.16.840.1.113883.6.1" displayName="SPL UNCLASSIFIED SECTION"/>
                     <title>Adults</title>
                     <text>
                        <paragraph>10 to 50 mg                        intravenously at a rate generally not exceeding 25 mg/min, or
                                    deep intramuscularly; 100 mg if required; maximum daily dosage
                                    is 400 mg.</paragraph>
                        <paragraph>
                           <content styleCode="bold">Parenteral drug products should be
                                        inspected visually for particulate matter and discoloration
                                        prior to administration, whenever solution and container
                                        permit.</content>
                        </paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_ca39efa6-167d-4508-8265-c43ab1dbc4d3">
               <id root="d88dcbd8-e931-4d32-b43a-6420050c0491"/>
               <code code="34069-5" codeSystem="2.16.840.1.113883.6.1" displayName="HOW SUPPLIED SECTION"/>
               <title>HOW SUPPLIED</title>
               <text>
                  <paragraph>Diphenhydramine Hydrochloride Injection, USP 50 mg/mL</paragraph>
                  <paragraph>1 mL vials packaged in 25s (NDC 0641-6282-25)</paragraph>
               </text>
               <effectiveTime value="20250403"/>
               <component>
                  <section ID="LINK_5b00183d-557e-4ed6-b3a2-ec94f93bd0f2">
                     <id root="033e2341-5632-4011-816a-c5acf0b5469d"/>
                     <code code="44425-7" codeSystem="2.16.840.1.113883.6.1" displayName="STORAGE AND HANDLING SECTION"/>
                     <title>Storage</title>
                     <text>
                        <paragraph>
                           <content styleCode="bold">Protect from light. Keep covered in carton until time of use. Store at 20° to 25<content styleCode="bold">°</content>C (68<content styleCode="bold">° to </content>77<content styleCode="bold">°</content>F), excursions permitted to 15<content styleCode="bold">° to </content>30<content styleCode="bold">°</content>C (59<content styleCode="bold">° to </content>86<content styleCode="bold">°</content>F) [See USP Controlled Room Temperature].</content>
                        </paragraph>
                        <paragraph>To report SUSPECTED ADVERSE REACTIONS, contact Hikma Pharmaceuticals USA Inc. at 1-877-845-0689, or the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.<br/>
For Product Inquiry call 1-877-845-0689.</paragraph>
                        <paragraph>
                           <content styleCode="bold">Manufactured by:</content>
                           <br/>
Hikma Pharmaceuticals USA Inc.<br/>
Berkeley Heights, NJ 07922</paragraph>
                        <paragraph>
                           <content styleCode="bold">
                              <renderMultiMedia referencedObject="MM2"/>
                           </content>
                        </paragraph>
                        <paragraph>Revised July 2023<br/>
                           <br/>
463-027-00</paragraph>
                     </text>
                     <effectiveTime value="20250403"/>
                     <component>
                        <observationMedia ID="MM2">
                           <text>logo</text>
                           <value xsi:type="ED" mediaType="image/jpeg">
                              <reference value="diphenhydramine-novaplus-2.jpg"/>
                           </value>
                        </observationMedia>
                     </component>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="LINK_a82dc817-ba87-448d-9027-8a8756668b6c">
               <id root="a5526337-fc03-4e70-a23e-49da48e64df6"/>
               <code code="51945-4" codeSystem="2.16.840.1.113883.6.1" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>PRINCIPAL DISPLAY PANEL</title>
               <text>
                  <paragraph>NDC 0641-<content styleCode="bold">6282-01</content>        Rx only<br/>
                     <content styleCode="bold">DiphenhydrAMINE<br/>
Hydrochloride Injection, USP<br/>
50 mg/mL<br/>
HIGH POTENCY<br/>
For IM or IV use<br/>
Protect from light<br/>
                     </content>1 mL Vial</paragraph>
                  <paragraph> <renderMultiMedia referencedObject="MM3"/>
                  </paragraph>
                  <paragraph>NDC 0641-<content styleCode="bold">6282</content>-25        Rx only<br/>
                     <content styleCode="bold">DiphenhydrAMINE<br/>
Hydrochloride Injection, USP<br/>
50 mg/mL<br/>
HIGH POTENCY<br/>
For deep Intramuscular<br/>
or slow Intravenous use<br/>
                     </content>25 x 1 mL Vials</paragraph>
                  <renderMultiMedia referencedObject="MM4"/>
               </text>
               <effectiveTime value="20250403"/>
               <component>
                  <observationMedia ID="MM3">
                     <text>unit label</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="diphenhydramine-novaplus-3.jpg"/>
                     </value>
                  </observationMedia>
               </component>
               <component>
                  <observationMedia ID="MM4">
                     <text>carton label</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="diphenhydramine-novaplus-4.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>